Semin Respir Crit Care Med 2016; 37(04): 640-646
DOI: 10.1055/s-0036-1584803
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Antivirals for Respiratory Viral Infections: Problems and Prospects

Qiang Liu*
1  The First College of Clinical Medical Science, China Three Gorges University/Yichang Central People's Hospital, Yichang, China
,
Yuan-hong Zhou*
1  The First College of Clinical Medical Science, China Three Gorges University/Yichang Central People's Hospital, Yichang, China
,
Feng Ye*
1  The First College of Clinical Medical Science, China Three Gorges University/Yichang Central People's Hospital, Yichang, China
,
Zhan-qiu Yang
2  State Key Laboratory of Virology, Institute of Medical Virology, School of Medicine, Wuhan University, Wuhan, China
› Author Affiliations
Further Information

Publication History

Publication Date:
03 August 2016 (online)

Abstract

In the past two decades, several newly emerging and reemerging viral respiratory pathogens including several influenza viruses (avian influenza and pandemic influenza), severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East respiratory syndrome coronavirus (MERS-CoV), have continued to challenge medical and public health systems. Thereafter, the development of cost-effective, broad-spectrum antiviral agents is the urgent mission of both virologists and pharmacologists. Current antiviral developments have focused targets on viral entry, replication, release, and intercellular pathways essential for viral life cycle. Here, we review the current literature on challenges and prospects in the development of these antivirals.

* All three authors contributed equally to this work.